It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The numerous enzymes and cofactors involved in eukaryotic DNA replication are conserved from yeast to human, and the budding yeast Saccharomyces cerevisiae (S.c.) has been a useful model organism for these studies. However, there is a gap in our knowledge of why replication origins in higher eukaryotes do not use a consensus DNA sequence as found in S.c. Using in vitro reconstitution and single-molecule visualization, we show here that S.c. origin recognition complex (ORC) stably binds nucleosomes and that ORC-nucleosome complexes have the intrinsic ability to load the replicative helicase MCM double hexamers onto adjacent nucleosome-free DNA regardless of sequence. Furthermore, we find that Xenopus laevis nucleosomes can substitute for yeast ones in engaging with ORC. Combined with re-analyses of genome-wide ORC binding data, our results lead us to propose that the yeast origin recognition machinery contains the cryptic capacity to bind nucleosomes near a nucleosome-free region and license origins, and that this nucleosome-directed origin licensing paradigm generalizes to all eukaryotes.
Most eukaryotes do not use a consensus DNA sequence as binding sites for the origin recognition complex (ORC) to initiate DNA replication, however budding yeast do. Here the authors show S. cerevisiae ORC can bind nucleosomes near nucleosome-free regions and recruit replicative helicases to form a pre-replication complex independent of the DNA sequence.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; O’Donnell, Michael E. 3 ; Liu, Shixin 1
1 The Rockefeller University, Laboratory of Nanoscale Biophysics and Biochemistry, New York, USA (GRID:grid.134907.8) (ISNI:0000 0001 2166 1519)
2 The Rockefeller University, Laboratory of Nanoscale Biophysics and Biochemistry, New York, USA (GRID:grid.134907.8) (ISNI:0000 0001 2166 1519); Syros Pharmaceuticals, Cambridge, USA (GRID:grid.134907.8)
3 The Rockefeller University, Laboratory of DNA Replication, New York, USA (GRID:grid.134907.8) (ISNI:0000 0001 2166 1519); The Rockefeller University, Howard Hughes Medical Institute, New York, USA (GRID:grid.134907.8) (ISNI:0000 0001 2166 1519)
4 The Pennsylvania State University, Center for Eukaryotic Gene Regulation, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281); The Pennsylvania State University, Department of Biochemistry and Molecular Biology, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281); The Pennsylvania State University, Department of Physics, University Park, USA (GRID:grid.29857.31) (ISNI:0000 0001 2097 4281)




